Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial
Open Access
- 1 March 2012
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 14 (3) , 278-286
- https://doi.org/10.1093/eurjhf/hfr177
Abstract
Aims Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical va...Keywords
This publication has 14 references indexed in Scilit:
- Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute DyspneaJournal of the American College of Cardiology, 2010
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract InfectionsJAMA, 2009
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialThe Lancet, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Influence of Deviation From Guidelines on the Outcome of Community-Acquired PneumoniaChest, 2002
- Regression Modeling StrategiesPublished by Springer Nature ,2001
- A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unitIntensive Care Medicine, 1995
- Effects of prehospital medications on mortality and length of stay in congestive heart failureAnnals of Emergency Medicine, 1992
- Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort studyThe American Journal of Medicine, 1990